Pharma Research Products Co., Ltd logo

Pharma Research Products Co., Ltd (214450)

Market Open
10 Aug, 06:30
KRX SM KRX SM
410,000. 00
+31,500
+8.3223%
- Market Cap
- P/E Ratio
950% Div Yield
243,489 Volume
9,117.91 Eps
378,500
Previous Close
Add Transaction
Day Range
377,500 412,000
Year Range
255,000 713,000
Want to track 214450 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Pharma Research Products Co., Ltd (214450) Statistics

Valuation metrics

Market Cap -
Enterprise value 3.94T
Trailing P/E (ttm) 22.28
Forward P/E -
PEG ratio 0.39
Price/Sales (ttm) 6.96
Price/Book (mrq) 5.78
Enterprise Value/Revenue 6.98
Enterprise Value/EBITDA 16.6

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 289.52K
Average volume (90 days) 157.18K

Price summary

52-Week low 255,000
52-Week high 713,000
Beta -
50-Day moving average 340,957.14
200-Day moving average 334,648.15

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1,100
Trailing annual dividend yield 0.0029%
5-Year annual dividend yield -
Payout ratio 0.06
Dividend Date 17 Apr 2026
Ex-Dividend Date 29 Dec 2025
Last split factor 0.74:1
Last split Date 30 Oct 2025

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.31%
Operating margin 0.4%

Operational effectiveness

Return on assets 0.16%
Return on equity 0.27%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 53,063.37
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 16,581.02
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 59,249.98
Total debt (mrq) -
Total Debt/Equity (mrq) 0.31
Current ratio (mrq) 5.69%
Book value per share (mrq) 68,802.95

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -